Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Mol Biol ; 432(14): 3989-4009, 2020 06 26.
Artículo en Inglés | MEDLINE | ID: mdl-32304700

RESUMEN

The impenetrability of the blood-brain barrier (BBB) to most conventional drugs impedes the treatment of central nervous system (CNS) disorders. Interventions for diseases like brain cancer, neurodegeneration, or age-associated inflammatory processes require varied approaches to CNS drug delivery. Cystine-dense peptides (CDPs) have drawn recent interest as drugs or drug-delivery vehicles. Found throughout the phylogenetic tree, often in drug-like roles, their size, stability, and protein interaction capabilities make CDPs an attractive mid-size biologic scaffold to complement conventional antibody-based drugs. Here, we describe the identification, maturation, characterization, and utilization of a CDP that binds to the transferrin receptor (TfR), a native receptor and BBB transporter for the iron chaperone transferrin. We developed variants with varying binding affinities (KD as low as 216 pM), co-crystallized it with the receptor, and confirmed murine cross-reactivity. It accumulates in the mouse CNS at ~25% of blood levels (CNS blood content is only ~1%-6%) and delivers neurotensin, an otherwise non-BBB-penetrant neuropeptide, at levels capable of modulating CREB signaling in the mouse brain. Our work highlights the utility of CDPs as a diverse, easy-to-screen scaffold family worthy of inclusion in modern drug discovery strategies, demonstrated by the discovery of a candidate CNS drug delivery vehicle ready for further optimization and preclinical development.


Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Enfermedades del Sistema Nervioso Central/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Péptidos/farmacología , Animales , Antígenos CD/química , Antígenos CD/efectos de los fármacos , Antígenos CD/genética , Antígenos CD/farmacología , Sistema Nervioso Central/efectos de los fármacos , Cistina/química , Cistina/genética , Humanos , Inflamación/tratamiento farmacológico , Inflamación/patología , Ratones , Neuropéptidos/química , Neuropéptidos/farmacología , Neurotensina/química , Neurotensina/farmacología , Péptidos/química , Unión Proteica/efectos de los fármacos , Receptores de Transferrina/química , Receptores de Transferrina/efectos de los fármacos , Receptores de Transferrina/genética
2.
Nat Struct Mol Biol ; 27(4): 342-350, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32203491

RESUMEN

Protein engineering has enabled the design of molecular scaffolds that display a wide variety of sizes, shapes, symmetries and subunit compositions. Symmetric protein-based nanoparticles that display multiple protein domains can exhibit enhanced functional properties due to increased avidity and improved solution behavior and stability. Here we describe the creation and characterization of a computationally designed circular tandem repeat protein (cTRP) composed of 24 identical repeated motifs, which can display a variety of functional protein domains (cargo) at defined positions around its periphery. We demonstrate that cTRP nanoparticles can self-assemble from smaller individual subunits, can be produced from prokaryotic and human expression platforms, can employ a variety of cargo attachment strategies and can be used for applications (such as T-cell culture and expansion) requiring high-avidity molecular interactions on the cell surface.


Asunto(s)
Nanopartículas/química , Ingeniería de Proteínas , Proteínas/química , Secuencias Repetidas en Tándem/genética , Secuencias de Aminoácidos/genética , Técnicas de Cultivo de Célula , Humanos , Modelos Moleculares , Dominios Proteicos/genética , Estabilidad Proteica , Proteínas/genética , Linfocitos T/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA